Christophe Chardot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christophe Chardot has a total of 334 co-authors. Here are the top co-authors by number of shared publications:
Carmen Capito
Pediatric Surgery, Hôpital Universitaire Necker‐Enfants Malades Paris France
9 shared publicationsFlorence Lacaille
Pediatric Gastroenterology‐Nutrition and Hepatology Units, Necker Enfants Malades Hospital, APHP, Université Paris Cité Paris France
4 shared publications- Florence Lacaille
Gastroenterology-Hepatology-Nutrition Unit, Hôpital Necker-Enfants Malades, Paris, France
4 shared publications - Anaïs Brassier
Reference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité Paris France
3 shared publications - Claire Francoz
Service d'Hépatologie et Transplantation Hépatique Hôpital Beaujon, APHP Clichy France
3 shared publications Claire Mayer
Pediatric Hepatology, Hôpital Universitaire Necker‐Enfants Maladies Filière Filfoie, ERN Rare‐Liver and TransplantChild Paris France
3 shared publications
Latest Publications
- 4 September 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-5
Kidney transplantation in children with extended ilio-caval thrombosis
- 4 September 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-5
Kidney transplantation in children with extended ilio-caval thrombosis
- Open Access
- 16 July 2026
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (4) , e70223
Liver Cancer in Methylmalonic and Propionic Acidemias: A Rare Complication? A Clinico‐Pathological Study of 24 Livers
In methylmalonic (MMA) and propionic acidemias (PA), liver or liver‐kidney transplantation (Tx) is indicated for metabolic decompensations, kidney failure (MMA), and to improve quality of life. Liver cancer was reported in five patients with MMA. We characterized the pathology of 23 explanted livers and one cancer to investigate for pre‐cancerous changes. We included seven patients with PA, 16 with MMA, and a patient with cancer after kidney Tx for MMA. Liver function tests, alpha‐foetoprotein, and liver ultrasound were collected. Routine and special stains were performed. Abnormalities were observed in liver tests or ultrasound in half of the patients. Two had cirrhosis (one MMA, one PA). The maximum alpha‐foetoprotein was 28 ng/mL. The key lesion was clusters and nodules of clear cells in 83%: distended hepatocytes with central nuclei, sharply demarcated from the parenchyma, in the periportal area. These cells contained less glycogen than the surrounding liver; macro‐vacuolar steatosis was observed in 20%. Fibrosis was present in all but two, mostly stage 1 (67%), and mild lymphocytic inflammation in the portal tracts. Large‐cell dysplasia was observed in the three oldest patients (one PA, two MMA). The phenotype of the clusters and nodules highlighted mitochondrial and LFABP loss. Abnormal labelling of glutamine synthetase was seen at distance from the nodules. The liver cancer was a hepatocellular carcinoma. Liver abnormalities were observed in all patients. The clusters and nodules of clear cells likely originate from propionyl‐CoA accumulation and mitochondrial dysfunction. This abnormal pathology pleads for early liver Tx. Regular liver monitoring is recommended with alpha‐foetoprotein and ultrasound.
- 16 July 2026
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (4) , e70223
Open AccessLiver Cancer in Methylmalonic and Propionic Acidemias: A Rare Complication? A Clinico‐Pathological Study of 24 Livers
In methylmalonic (MMA) and propionic acidemias (PA), liver or liver‐kidney transplantation (Tx) is indicated for metabolic decompensations, kidney failure (MMA), and to improve quality of life. Liver cancer was reported in five patients with MMA. We characterized the pathology of 23 explanted livers and one cancer to investigate for pre‐cancerous changes. We included seven patients with PA, 16 with MMA, and a patient with cancer after kidney Tx for MMA. Liver function tests, alpha‐foetoprotein, and liver ultrasound were collected. Routine and special stains were performed. Abnormalities were observed in liver tests or ultrasound in half of the patients. Two had cirrhosis (one MMA, one PA). The maximum alpha‐foetoprotein was 28 ng/mL. The key lesion was clusters and nodules of clear cells in 83%: distended hepatocytes with central nuclei, sharply demarcated from the parenchyma, in the periportal area. These cells contained less glycogen than the surrounding liver; macro‐vacuolar steatosis was observed in 20%. Fibrosis was present in all but two, mostly stage 1 (67%), and mild lymphocytic inflammation in the portal tracts. Large‐cell dysplasia was observed in the three oldest patients (one PA, two MMA). The phenotype of the clusters and nodules highlighted mitochondrial and LFABP loss. Abnormal labelling of glutamine synthetase was seen at distance from the nodules. The liver cancer was a hepatocellular carcinoma. Liver abnormalities were observed in all patients. The clusters and nodules of clear cells likely originate from propionyl‐CoA accumulation and mitochondrial dysfunction. This abnormal pathology pleads for early liver Tx. Regular liver monitoring is recommended with alpha‐foetoprotein and ultrasound.
- Open Access
- 5 July 2026
- Published by Wiley in American Journal of Hematology
- Vol. 101 (10) , 2654-2658
Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count
- 5 July 2026
- Published by Wiley in American Journal of Hematology
- Vol. 101 (10) , 2654-2658
Open AccessSubtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count
- Open Access
- 25 June 2026
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (4) , e70216
Long Term Follow‐Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study
Propionic acidemia (PA) is a rare inherited metabolic disorder associated with recurrent metabolic decompensations and chronic multisystemic complications. Liver transplantation (LT) may improve metabolic stability, but its long‐term impact on organ involvement remains debated. We retrospectively studied 20 patients with PA transplanted between 1993 and 2024 in three French reference centers. Clinical, biochemical, and organ‐specific data were collected before and after transplantation. Eighteen isolated LT and two combined liver–kidney transplantations were performed. Median age at transplantation was 13.6 years; median follow‐up was 4.5 years. Indications included frequent metabolic decompensation (70%) and cardiomyopathy (35%). Four patients died perioperatively, three from cardiac causes; crude survival was 75%. Transplantation markedly improved metabolic stability and allowed significant dietary liberalization, with reduced need for enteral feeding. Cardiac involvement, present in 15 patients pre‐transplant, showed variable evolution: 10 improved initially, but three deteriorated later, and one required heart transplantation. New neurological manifestations occurred in eight patients, with acute episodes including CNI‐related encephalopathy. Psychiatric disorders progressed from 40% to 59% of patients, requiring treatment in seven. Renal impairment worsened post‐LT to 70%, with mean measured glomerular filtration rate declining from 72 to 60 mL/min/1.73 m 2 . LT improves metabolic and nutritional outcomes but does not consistently prevent chronic organ complications. In conclusion, early LT, before the onset of cardiac, neurologic, and psychiatric manifestations, should be considered on a case‐by‐case basis, as we could not demonstrate correlation between age at transplantation and organ involvement.
- 25 June 2026
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (4) , e70216
Open AccessLong Term Follow‐Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study
Propionic acidemia (PA) is a rare inherited metabolic disorder associated with recurrent metabolic decompensations and chronic multisystemic complications. Liver transplantation (LT) may improve metabolic stability, but its long‐term impact on organ involvement remains debated. We retrospectively studied 20 patients with PA transplanted between 1993 and 2024 in three French reference centers. Clinical, biochemical, and organ‐specific data were collected before and after transplantation. Eighteen isolated LT and two combined liver–kidney transplantations were performed. Median age at transplantation was 13.6 years; median follow‐up was 4.5 years. Indications included frequent metabolic decompensation (70%) and cardiomyopathy (35%). Four patients died perioperatively, three from cardiac causes; crude survival was 75%. Transplantation markedly improved metabolic stability and allowed significant dietary liberalization, with reduced need for enteral feeding. Cardiac involvement, present in 15 patients pre‐transplant, showed variable evolution: 10 improved initially, but three deteriorated later, and one required heart transplantation. New neurological manifestations occurred in eight patients, with acute episodes including CNI‐related encephalopathy. Psychiatric disorders progressed from 40% to 59% of patients, requiring treatment in seven. Renal impairment worsened post‐LT to 70%, with mean measured glomerular filtration rate declining from 72 to 60 mL/min/1.73 m 2 . LT improves metabolic and nutritional outcomes but does not consistently prevent chronic organ complications. In conclusion, early LT, before the onset of cardiac, neurologic, and psychiatric manifestations, should be considered on a case‐by‐case basis, as we could not demonstrate correlation between age at transplantation and organ involvement.
- Open Access
- 9 June 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (7) , 2518-2522
In-situ hypothermic preservation of the distal limb during thigh and femoral vessel resection and rotationplasty in a child with sarcoma: a case report
Background: The management of pediatric sarcomas of the upper thigh involving femoral vessels is challenging. While rotationplasty offers a valuable functional alternative to amputation, ischemia–reperfusion injury of the re-implanted distal limb may compromise the outcome after this procedure. Hypothermic in situ preservation of the distal limb may reduce ischemia–reperfusion–related complications. Methods: We report on the case of a 6-year-old girl presenting with a sarcoma of the thigh involving the femoral vessels. While performing en bloc resection of the upper thigh and femoral vessels, in-situ hypothermic preservation of the distal lower limb was used. Auto-transplantation of the distal lower limb was then completed with rotationplasty to facilitate further prosthesis adaptation and improve functional outcomes. Results: The postoperative course was uneventful. No ischemia–reperfusion–related complications occurred, and complete skin healing was achieved within 1 week. Histopathological examination of the resected tumor confirmed a good oncological response with clear margins. The patient is alive and well, in complete tumor remission 12 months after the operation, with a satisfactory functional outcome of the rotationplasty. Conclusion: In-situ hypothermic preservation is a simple technique that can reduce ischemia–reperfusion injury during complex thigh resection and auto-transplantation of the distal lower limb. It contributes to a straightforward post-operative course and avoids delays in oncological treatment.
- 9 June 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (7) , 2518-2522
Open AccessIn-situ hypothermic preservation of the distal limb during thigh and femoral vessel resection and rotationplasty in a child with sarcoma: a case report
Background: The management of pediatric sarcomas of the upper thigh involving femoral vessels is challenging. While rotationplasty offers a valuable functional alternative to amputation, ischemia–reperfusion injury of the re-implanted distal limb may compromise the outcome after this procedure. Hypothermic in situ preservation of the distal limb may reduce ischemia–reperfusion–related complications. Methods: We report on the case of a 6-year-old girl presenting with a sarcoma of the thigh involving the femoral vessels. While performing en bloc resection of the upper thigh and femoral vessels, in-situ hypothermic preservation of the distal lower limb was used. Auto-transplantation of the distal lower limb was then completed with rotationplasty to facilitate further prosthesis adaptation and improve functional outcomes. Results: The postoperative course was uneventful. No ischemia–reperfusion–related complications occurred, and complete skin healing was achieved within 1 week. Histopathological examination of the resected tumor confirmed a good oncological response with clear margins. The patient is alive and well, in complete tumor remission 12 months after the operation, with a satisfactory functional outcome of the rotationplasty. Conclusion: In-situ hypothermic preservation is a simple technique that can reduce ischemia–reperfusion injury during complex thigh resection and auto-transplantation of the distal lower limb. It contributes to a straightforward post-operative course and avoids delays in oncological treatment.
- 21 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (7) , 163091
Is a history of umbilical vein catheterization a contraindication to Meso-Rex bypass for extrahepatic portal vein obstruction in children?
- 21 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (7) , 163091
Is a history of umbilical vein catheterization a contraindication to Meso-Rex bypass for extrahepatic portal vein obstruction in children?
- Open Access
- 13 March 2026
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (2) , e70165
Acute Neurological Complications After Transplantation in Methylmalonic Acidemia: A 35‐Patient French Cohort
Transplantation is an effective therapeutic option to improve quality of life in patients with severe methylmalonic acidemia (MMA). However, data regarding neurological complications following transplantation remain limited. A retrospective, single‐center study was conducted at Necker Hospital (France), including MMA patients who underwent kidney (KT), liver (LT), or liver‐kidney transplantation (LKT) between 2007 and 2022. Our aim was to evaluate acute neurological complications occurring after transplantation, focusing on clinical features, laboratory parameters and neuroimaging. Sensorineural complications were also assessed. Thirty‐five patients were included, 21 had undergone LKT, 10 LT and 4 KT. The median age at transplantation was 10.1 years, with a median follow‐up of 5 years. Tacrolimus was used in 91% of patients. Acute neurological complications likely related to MMA occurred in 17% of patients. They include Leigh syndrome with identifiable triggers, observed in 4 patients (2 early and 2 late‐post‐transplantation), leading to one early‐ and one late‐onset death. Stroke‐like episodes occurred in 2 patients. Non‐epileptic myoclonus, likely related to calcineurin inhibitor (CNI), were reported in 31% of patients. Pre‐transplant brain MRI showed nonspecific abnormalities in 31% of patients and remained stable afterwards. Post‐transplant ophthalmological data available for 17 patients showed 3 optic atrophies. No acute vision or hearing loss was reported. Although transplantation improves metabolic control in MMA, acute neurological complications can still occur following a triggering event, even years after transplantation. The risk may arise from sensitivity to CNI‐induced neurotoxicity. Pre‐ and post‐transplant neuroimaging, emergency metabolic protocols, and tailored immunosuppression are essential for long‐term management.
- 13 March 2026
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (2) , e70165
Open AccessAcute Neurological Complications After Transplantation in Methylmalonic Acidemia: A 35‐Patient French Cohort
Transplantation is an effective therapeutic option to improve quality of life in patients with severe methylmalonic acidemia (MMA). However, data regarding neurological complications following transplantation remain limited. A retrospective, single‐center study was conducted at Necker Hospital (France), including MMA patients who underwent kidney (KT), liver (LT), or liver‐kidney transplantation (LKT) between 2007 and 2022. Our aim was to evaluate acute neurological complications occurring after transplantation, focusing on clinical features, laboratory parameters and neuroimaging. Sensorineural complications were also assessed. Thirty‐five patients were included, 21 had undergone LKT, 10 LT and 4 KT. The median age at transplantation was 10.1 years, with a median follow‐up of 5 years. Tacrolimus was used in 91% of patients. Acute neurological complications likely related to MMA occurred in 17% of patients. They include Leigh syndrome with identifiable triggers, observed in 4 patients (2 early and 2 late‐post‐transplantation), leading to one early‐ and one late‐onset death. Stroke‐like episodes occurred in 2 patients. Non‐epileptic myoclonus, likely related to calcineurin inhibitor (CNI), were reported in 31% of patients. Pre‐transplant brain MRI showed nonspecific abnormalities in 31% of patients and remained stable afterwards. Post‐transplant ophthalmological data available for 17 patients showed 3 optic atrophies. No acute vision or hearing loss was reported. Although transplantation improves metabolic control in MMA, acute neurological complications can still occur following a triggering event, even years after transplantation. The risk may arise from sensitivity to CNI‐induced neurotoxicity. Pre‐ and post‐transplant neuroimaging, emergency metabolic protocols, and tailored immunosuppression are essential for long‐term management.
- Open Access
- 29 November 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 84 (5) , 906-919
Targeting ATR to overcome cisplatin resistance in hepatoblastoma
- 29 November 2025
- Published by Elsevier in Journal of Hepatology
- Vol. 84 (5) , 906-919
Open AccessTargeting ATR to overcome cisplatin resistance in hepatoblastoma
- 7 August 2025
- Published by Wolters Kluwer Health in Annals of Surgery
IBD-linked Genetic Variance in Intestinal Transplantation
Background: In solid organ transplantation, the intestine remains the most challenging. Previous studies have linked NOD2 genetic variation to intestinal transplantation (ITx) outcomes. Since then, a larger set of inflammatory bowel disease-associated genetic variants (IBDGVs) has been identified. This study aims to explore the prevalence and association of these IBDGVs with ITx outcomes. Method: Clinical data and DNA from 150 donor/recipient pairs were collected from 5 ITx centers (Leuven, Cambridge, Paris, Madrid, Buenos Aires). Genotyping-by-sequencing of 540 IBDGVs was performed, and genetic European individuals (53 donors, 101 recipients, EUR cohort) were selected. Associations between ITx outcomes (patient/graft survival and acute/chronic rejection (AR/CR)) and IBDGVs were separately analyzed for donors, recipients, and donor-AND-recipient using Cox regression, followed by pathway analysis (PP<0.05) were identified between IBDGVs and ITx outcomes, including 79 with AR, 34 with CR, 113 with patient survival and 102 with graft survival. Donor/recipient IBDGVs had mixed protective (HR1) on outcomes, while donor-AND-recipient IBDGVs were predominantly harmful. Pathway analysis of donor-AND-recipient IBDGV-related genes showed enrichment in innate/adaptive immunity and epithelial barrier function, particularly in IL-12 and S100 family signaling, phagosome formation, and microbial pattern recognition. Upstream regulatory analysis confirmed the link to microbial sensing (31% of the genes) and antibody-mediated immune responses (20%). Conclusion: Several IBDGVs associated with ITx outcomes were identified in a multicenter genetic European cohort. These findings highlight potential markers for improving donor selection and post-transplant management.
- 7 August 2025
- Published by Wolters Kluwer Health in Annals of Surgery
IBD-linked Genetic Variance in Intestinal Transplantation
Background: In solid organ transplantation, the intestine remains the most challenging. Previous studies have linked NOD2 genetic variation to intestinal transplantation (ITx) outcomes. Since then, a larger set of inflammatory bowel disease-associated genetic variants (IBDGVs) has been identified. This study aims to explore the prevalence and association of these IBDGVs with ITx outcomes. Method: Clinical data and DNA from 150 donor/recipient pairs were collected from 5 ITx centers (Leuven, Cambridge, Paris, Madrid, Buenos Aires). Genotyping-by-sequencing of 540 IBDGVs was performed, and genetic European individuals (53 donors, 101 recipients, EUR cohort) were selected. Associations between ITx outcomes (patient/graft survival and acute/chronic rejection (AR/CR)) and IBDGVs were separately analyzed for donors, recipients, and donor-AND-recipient using Cox regression, followed by pathway analysis (PP<0.05) were identified between IBDGVs and ITx outcomes, including 79 with AR, 34 with CR, 113 with patient survival and 102 with graft survival. Donor/recipient IBDGVs had mixed protective (HR1) on outcomes, while donor-AND-recipient IBDGVs were predominantly harmful. Pathway analysis of donor-AND-recipient IBDGV-related genes showed enrichment in innate/adaptive immunity and epithelial barrier function, particularly in IL-12 and S100 family signaling, phagosome formation, and microbial pattern recognition. Upstream regulatory analysis confirmed the link to microbial sensing (31% of the genes) and antibody-mediated immune responses (20%). Conclusion: Several IBDGVs associated with ITx outcomes were identified in a multicenter genetic European cohort. These findings highlight potential markers for improving donor selection and post-transplant management.
- Open Access
- 12 December 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (6) , 954-966
Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival
- 12 December 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (6) , 954-966
Open AccessIdentification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival